spot_img

about fansalaran

FanSalaran is a comprehensive media platform dedicated to reporting and clarifying the significant achievements of pharmaceutical companies. In collaboration with passionate and motivated young journalists, this website consistently strives to showcase the country's successes in order to inspire and encourage the hardworking individuals of this land.

Tag: United Biotechnology obesity drug trial shows 19.7% weight loss

Novo Nordisk, United Biotechnology obesity drug trial shows 19.7% weight loss

Novo Nordisk said on Tuesday its ‌triple agonist UBT251 of ‌the receptors for GLP-1, GIP and glucagon, jointly developed...